 |
Processa Pharmaceuticals
PCSA
|
7.47 |
$ 2.3 |
-1.29 % |
$ 3.01 M |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Albireo Pharma
ALBO
|
14.7 |
- |
-0.23 % |
$ 916 M |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Ascendis Pharma A/S
ASND
|
132 |
$ 220.9 |
2.49 % |
$ 5 B |
Danmark |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 19.57 |
1.77 % |
$ 915 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Phathom Pharmaceuticals
PHAT
|
122 |
$ 10.47 |
4.08 % |
$ 763 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
AgeX Therapeutics
AGE
|
78.4 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
2.47 |
- |
- |
$ 546 M |
USA |
 |
Cara Therapeutics
CARA
|
52.4 |
- |
-3.03 % |
$ 260 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Pliant Therapeutics
PLRX
|
37.6 |
$ 1.31 |
2.34 % |
$ 80.4 M |
USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
239 |
$ 8.31 |
1.59 % |
$ 111 M |
USA |
 |
CRISPR Therapeutics AG
CRSP
|
1.1 K |
$ 47.09 |
1.42 % |
$ 4.23 B |
Schweiz |
 |
Cyclacel Pharmaceuticals
CYCC
|
81.5 K |
- |
-5.98 % |
$ 34.1 M |
USA |
 |
ChemoCentryx
CCXI
|
3.1 |
- |
- |
$ 3.74 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
56.5 |
- |
- |
$ 2.02 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
115 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
Palatin Technologies
PTN
|
119 |
$ 21.0 |
5.79 % |
$ 19.5 M |
USA |
 |
Pulmatrix
PULM
|
21.7 |
$ 2.12 |
-1.4 % |
$ 7.74 M |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
50 |
$ 4.53 |
5.1 % |
$ 868 M |
Canada |